ArticleDisease models & mechanisms2019

A yeast-based screening assay identifies repurposed drugs that suppress mitochondrial fusion and mtDNA maintenance defects.

Thomas Delerue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.